Pathology AI for Precision Medicine

Intelligence for the Decisions that Matter Most

Pathology's AI platform¹ for the experts answering medicine's biggest questions, from discovery through diagnosis.

Clinical LAB SOLUTIONS

At the point of review

An immersive, operationally intelligent review experience for pathology's experts.

CLINICAL

Life Sciences SOLUTIONS

From tissue to treatment

Turn tissue into biomarker insights, move therapies through development and get them to the patients who need them.

LIFE SCIENCES

Trusted by 16 of the top 20 pharma companies and over 4,000 hospitals and clinics globally.

CONCENTRIQ

Pathology AI for
Precision Medicine

The Concentriq¹ portfolio powers precision medicine from discovery through diagnosis, with purpose-built solutions for biomarker research, clinical trials, companion diagnostics, and case review.

EXPLORE CONCENTRIQ

Best in KLAS 2026

Concentriq is the highest-rated digital pathology platform in both the United States and Europe. Find out why we’re rated #1 by customers.

READ THE KLAS REPORT

Trusted at scale. Proven in practice.

12M

cases managed annually by Proscia's customers

4,000+

hospitals and clinics served worldwide

16 of 20

top pharmaceutical companies run on Concentriq

30,000+

studies powered by Concentriq, from discovery to trials

100%

of customers told KLAS they would buy Concentriq again

FEATS OF STRENGTH VIDEO SERIES

The hardest part of going digital isn't the technology.

Behind every successful digital pathology deployment is a pathologist or lab leader who broke down barriers and moved their organization to Pathology AI. Feats of Strength tells their stories.

SEE THEIR STORIES

"Understanding the needs from all of those groups of people, their various perspectives, packaging them into a justification that made sense for everybody and showed value to the entire organization, those were some of the most critical steps that we undertook."

Dr. Cherub Kim

Director, Medical Affairs and Clinical Informatics Lead

“Just go ahead and start. It’ll give you something to grow on.”

Dr. Amanda Hemmerich

Global Director of Digital Pathology Innovation
IQVIA Laboratories

"I think the defining moment for me was when I saw that first scanner and saw what it could do. It was like, okay, someday, this is the way we're gonna work.”

Dr. Derrick Forchetti

Pathologist
South Bend Medical Foundation

“I fully believed that this was the right thing to do. And I didn’t waver on that. At the end of the day, we’re doing it for the right reasons, patient care and a better workflow.”

Dr. Sajjad Malik

Medical Director of Digital Pathology
HNL Lab Medicine

Latest Resources

Blog

How We Built Intelligence into the Pathology Platform

We recently announced the Fifth Generation of Concentriq. This generation helps pathologists spend their time on high-judgment interpretation, and scientists move from an early signal to a confident program decision, faster. It does this by building clinically and scientifically grounded intelligence into the workflows experts already use across drug discovery, development, and case review. Our announcement covered what we built and why we built it. This post is about the how.

Press Release

Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists

Built on a new AI-native architecture, Concentriq delivers clinically and scientifically grounded intelligence to decisions throughout drug discovery, development, and case review.

Webinar

Meet the Next Generation of Concentriq: Pathology’s AI Platform for Precision Medicine

Diagnostic labs and drug development programs are under more pressure than ever — and a pathology platform with AI bolted on can't keep up. See the first official demo of Concentriq Fifth Generation, built with an enterprise AI layer at its core. Hear directly from customers optimizing clinical diagnostic workflows and advancing drug development research.

Save my spot

View all

¹ The Concentriq portfolio includes distinct configurations. Concentriq AP-Dx is cleared for primary clinical diagnosis. Concentriq AP and Concentriq LS are for Research Use Only; not for use in diagnostic procedures. Proscia’s interoperable AI applications and native AI features are available for research use only on Concentriq AP. In some geographies, certain AI applications may be interoperable with Concentriq AP-Dx. Contact the AI application manufacturers for regulatory authorization status and indications for use. Proscia’s native AI features in Concentriq AP-Dx do not meet the definition of Artificial Intelligence as defined by Regulation (EU) 2024/1689.